GSE186471 carnosol endothelial cell 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE186471_carnosol_endothelial cell_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE186471_carnosol_endothelial cell_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE186471_carnosol_endothelial cell_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE186471_carnosol_endothelial cell_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 3040

Gene

DPPA2 upstream binding RNA

Gene

NSUN5 pseudogene 1

Gene

long intergenic non-protein coding RNA 1963

Gene

synaptotagmin 15B

Gene

long intergenic non-protein coding RNA 641

Gene

HLA complex group 11

Gene

ribosomal protein S6 kinase related

Gene

HERC2 pseudogene 9

Gene

PRR34 antisense RNA 1

  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    DPPA2 upstream binding RNA


  • Gene

    NSUN5 pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    synaptotagmin 15B


  • Gene

    long intergenic non-protein coding RNA 641


  • Gene

    HLA complex group 11


  • Gene

    ribosomal protein S6 kinase related


  • Gene

    HERC2 pseudogene 9


  • Gene

    PRR34 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.